A Clinical Study of HH-006 in Untreated Chronic Hepatitis B Virus Infected Patients

NCT07515209 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B Virus Infection

Interventions

BIOLOGICAL: HH-006
DRUG: 0.9% normal saline

Sponsor

Huahui Health